FDA Coronavirus
-
FDA approves first coronavirus drug, may help recoveryThe drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.WorldOct 22, 2020
-
‘Raise the bar’: Medical experts call for studies into accuracy of U.S. coronavirus testsMonths into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centres say it is time to do the studies to find out.HealthJun 14, 2020
